Combivir
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Antiretroviral (ARV) drugs are given in combination to treat the human immunodeficiency virus (HIV) infection and to prolong the…
Background:MERIT was a randomized trial comparing maraviroc (MVC) + Combivir versus efavirenz (EFV) + Combivir in drug-naive…
Abstract Adherence may be facilitated by reducing perceptual and practical barriers to antiretroviral therapy (ART). Practical…
Neil Martinson and colleagues report a randomized trial of adding short-course zidovudine+lamivudine to reduce drug resistance…
Combivir is a fixed dose combination tablet of two antiretroviral drugs; zidovudine and lamivudine, used in the treatment of HIV…
To compare the lipid and metabolic effects, efficacy, and safety of twice‐daily regimens of Trizivir® (abacavir 300 mg/lamivudine…
Objective: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial…
Objective: HIV‐1 protease inhibitors (versus no protease inhibitors) and stavudine (versus zidovudine) are independently…
Background Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a valid alternative to protease inhibitor…